Cobalamin and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cobalamin (vitamin b12) and Meropenem (meropenem). Common drug interactions include pneumonia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Cobalamin and Meropenem. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Cobalamin?

Cobalamin has active ingredients of vitamin b12. eHealthMe is studying from 3,429 Cobalamin users. Check the latest studies of Cobalamin.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

44 people who take Cobalamin and Meropenem together, and have interactions are studied.

Cobalamin and Meropenem drug interactions.

What are the common drug interactions of Cobalamin and Meropenem, by gender? *:

female:

Pneumonia
Diarrhoea
Respiratory failure (inadequate gas exchange by the respiratory system)
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
Vomiting
Nausea (feeling of having an urge to vomit)
Overdose
Platelet count decreased
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Brain abscess

male:

Pneumonia
Septic shock (shock due to blood infection)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Decreased appetite
Electrocardiogram qt prolonged
Generalised oedema (swelling all over the body)
Headache (pain in head)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Nausea (feeling of having an urge to vomit)
Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Cobalamin and Meropenem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Electrocardiogram qt prolonged
Haemoglobin decreased
Neuropathy peripheral (surface nerve damage)
Relapsing fever (bacterial infection characterized by recurring episodes of fever, headache, muscle and joint aches, and nausea)

40-49:

Brain abscess
Dysphagia (a condition in which swallowing is difficult or painful)
Haematochezia (passage of stools containing blood)
Mastication disorder (disease of chewing food)
Melaena (the passage of black, tarry stools)
Osteonecrosis of jaw (death of bone of jaw)
Otorrhoea (discharge from the ear)
Subcutaneous abscess
Arthralgia (joint pain)
Cardiomegaly (increased size of heart than normal)

50-59:

Constipation
Cough
Death
Diarrhoea
Fatigue (feeling of tiredness)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypokalaemia (low potassium)
Infection
Lymphoma (cancer that begins in immune system cells)

60+:

Pneumonia
Diarrhoea
Anaemia (lack of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Decreased appetite
Generalised oedema (swelling all over the body)
Headache (pain in head)

What are the existing conditions these people have? *

Constipation: 10 people, 22.73%
Multiple Myeloma (cancer of the plasma cells): 10 people, 22.73%
Fever: 8 people, 18.18%
High Blood Pressure: 8 people, 18.18%
Neuralgia (pain in one or more nerves): 7 people, 15.91%
Diabetes: 6 people, 13.64%
Pain: 6 people, 13.64%
Neuropathy Peripheral (surface nerve damage): 6 people, 13.64%
Insomnia (sleeplessness): 6 people, 13.64%
Local Anaesthesia: 5 people, 11.36%

* Approximation only. Some reports may have incomplete information.

Do you take Cobalamin and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously